Back
Protagonist Therapeutics Vs. Garmin Industry Stock Comparison
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
45.80
Seasonality Move:
18.58%
Buy
71
GRMN
Garmin
Last Price:
198.35
Seasonality Move:
4.43%
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.62. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Garmin (GRMN)
is a Buy
Is Garmin a Buy, Sell or Hold?
- The current Garmin [GRMN] share price is $204.92. The Score for GRMN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GRMN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.62
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | -140534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.33 - 47.23) | Buy |
| Bollinger Bands (100): | (35.43 - 45.45) | Buy |
GRMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 81.76 | Buy |
| Chaikin Money Flow: | 2350776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.79 - 177.51) | Buy |
| Bollinger Bands (100): | (162.52 - 177.74) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.18 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 44.76 | Buy |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 47.35 | Buy |
| 20-day EMA: | 46.42 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 35.57 | Buy |
GRMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.1 | Buy |
| 20-day SMA: | 167.91 | Buy |
| 50-day SMA: | 173.55 | Buy |
| 200-day SMA: | 157.19 | Buy |
| 8-day EMA: | 173.78 | Buy |
| 20-day EMA: | 170.36 | Buy |
| 50-day EMA: | 170.76 | Buy |
| 200-day EMA: | 157.44 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Garmin Earnings Growth & GRMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and an increase next year of $0.01 per share.
Protagonist Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Garmin Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||